Skip to content
Disclosery

TRV GP VI, LLC

Follow

13F filer, CIK 1990716, Boston, MA

TRV GP VI, LLC reported $41,971,955 across 4 holdings for the quarter ended 2025-03-31, in a 13F-HR filed 2025-05-09.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-25-004484

Period
2025-03-31
Reported value
$42M
Holdings
4
Top 10 weight
100%
New
0
Sold out
0

Largest buys vs the previous quarter

SecurityShares changeApprox. value
SEPNadded+1,059,203$6.13M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

None.

Holdings, Q1 2025

Share positions as resolved from 13F-HR 0000950123-25-004484, largest first. % of portfolio is the value over $41,971,955, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
SEPNSEPTERNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 3,152,456 shares; 2025Q1: 4,211,659 shares 4,211,659$24.4M58.1%+1,059,203Timeline
RAPPRAPPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 969,218 shares; 2025Q1: 969,218 shares 969,218$9.72M23.16%0Timeline
CARGO THERAPEUTICS INC COMCARGO THERAPEUTICS INC COMQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 1,867,119 shares; 2025Q1: 1,867,119 shares 1,867,119$7.6M18.11%0
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 194,174 shares; 2025Q1: 194,174 shares 194,174$266K0.63%0Timeline

How Q1 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950123-25-004484 base2025-05-09acceptance time not in the bulk data set